SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy

dc.creatorMerello, Marcelo Jorge
dc.creatorBhatia, Kailash P.
dc.creatorObeso, Jose A.
dc.date2021-02
dc.date.accessioned2023-08-31T00:06:07Z
dc.date.available2023-08-31T00:06:07Z
dc.identifierhttp://hdl.handle.net/11336/199210
dc.identifierMerello, Marcelo Jorge; Bhatia, Kailash P.; Obeso, Jose A.; SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy; Elsevier Science Inc.; Lancet Neurology; 20; 2; 2-2021; 94-95
dc.identifier1474-4422
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8543101
dc.descriptionDuring the pandemic it has become clear that severe acure respiratory syndrome coronavirus (SARS-CoV-2) causes not just respiratory disease, but can affect multiple organs and tissues. Of note is the involvement of the CNS and PNS, and the fact that this involvement is independent from the severity of the respiratory disease. Acute and subacute neurological complications of SARS-CoV-2 infections are reported in up to 85% of patients, including those with severe COVID-19, but also in otherwise minimally symptomatic or asymptomatic people. As many as 65% of people with COVID-19 present with hyposmia, which is also a common premotor symptom in Parkinson’s disease. This symptom, added to the fact that parkinsonism has been reported following COVID-19, has drawn the attention of the medical community to the hypothetical link between SARS-CoV-2 infection and Parkinson’s disease.
dc.descriptionFil: Merello, Marcelo Jorge. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.descriptionFil: Bhatia, Kailash P.. No especifíca;
dc.descriptionFil: Obeso, Jose A.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier Science Inc.
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/10.1016/S1474-4422(20)30442-7
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subjectPARKINSON
dc.subjectCOVID-19
dc.subjecthttps://purl.org/becyt/ford/3.2
dc.subjecthttps://purl.org/becyt/ford/3
dc.titleSARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución